JP2002532498A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002532498A5 JP2002532498A5 JP2000588174A JP2000588174A JP2002532498A5 JP 2002532498 A5 JP2002532498 A5 JP 2002532498A5 JP 2000588174 A JP2000588174 A JP 2000588174A JP 2000588174 A JP2000588174 A JP 2000588174A JP 2002532498 A5 JP2002532498 A5 JP 2002532498A5
- Authority
- JP
- Japan
- Prior art keywords
- heart
- occlusion
- experimetria
- racemate
- chest
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 210000000038 chest Anatomy 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 208000031225 myocardial ischemia Diseases 0.000 description 2
- 208000001778 Coronary Occlusion Diseases 0.000 description 1
- 206010011086 Coronary artery occlusion Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000008753 endothelial function Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 229960001412 pentobarbital Drugs 0.000 description 1
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000010410 reperfusion Effects 0.000 description 1
- 238000011699 spontaneously hypertensive rat Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU9802897 | 1998-12-14 | ||
| HU9802897A HU226617B1 (en) | 1998-12-14 | 1998-12-14 | Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, and pharmaceutical composition containing the compound as active ingredient |
| PCT/HU1999/000095 WO2000035914A1 (en) | 1998-12-14 | 1999-12-07 | Optically active pyridyl-4h-1,2,4-oxadiazine derivative and its use in the treatment of vascular diseases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011128516A Division JP5620340B2 (ja) | 1998-12-14 | 2011-06-08 | 光学活性ピリジル−４ｈ−１，２，４−オキサジアジン誘導体およびその血管疾患の治療における使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002532498A JP2002532498A (ja) | 2002-10-02 |
| JP2002532498A5 true JP2002532498A5 (https=) | 2007-02-08 |
Family
ID=10991166
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000588174A Withdrawn JP2002532498A (ja) | 1998-12-14 | 1999-12-07 | 光学活性ピリジル−４ｈ−１，２，４−オキサジアジン誘導体およびその血管疾患の治療における使用 |
| JP2011128516A Expired - Lifetime JP5620340B2 (ja) | 1998-12-14 | 2011-06-08 | 光学活性ピリジル−４ｈ−１，２，４−オキサジアジン誘導体およびその血管疾患の治療における使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011128516A Expired - Lifetime JP5620340B2 (ja) | 1998-12-14 | 2011-06-08 | 光学活性ピリジル−４ｈ−１，２，４−オキサジアジン誘導体およびその血管疾患の治療における使用 |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US6384029B1 (https=) |
| EP (1) | EP1147105B1 (https=) |
| JP (2) | JP2002532498A (https=) |
| KR (1) | KR100661774B1 (https=) |
| AT (1) | ATE266027T1 (https=) |
| AU (1) | AU765336B2 (https=) |
| BG (1) | BG65179B1 (https=) |
| BR (1) | BR9913982A (https=) |
| CA (1) | CA2340734C (https=) |
| CZ (1) | CZ300764B6 (https=) |
| DE (1) | DE69917074T2 (https=) |
| DK (1) | DK1147105T3 (https=) |
| EE (1) | EE04551B1 (https=) |
| ES (1) | ES2219091T3 (https=) |
| HR (1) | HRP20010133B1 (https=) |
| HU (1) | HU226617B1 (https=) |
| IL (1) | IL141515A (https=) |
| NO (1) | NO317649B1 (https=) |
| PL (1) | PL196584B1 (https=) |
| PT (1) | PT1147105E (https=) |
| RS (1) | RS50129B (https=) |
| RU (1) | RU2222538C2 (https=) |
| SI (1) | SI1147105T1 (https=) |
| SK (1) | SK285582B6 (https=) |
| UA (1) | UA70340C2 (https=) |
| WO (1) | WO2000035914A1 (https=) |
| ZA (1) | ZA200101182B (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005514418A (ja) | 2002-01-11 | 2005-05-19 | ビオレックス クタトー エス フェイレストェー アールテー． | カルボキサミジン誘導体及び血管疾患の治療におけるそれらの使用 |
| KR100678577B1 (ko) * | 2006-09-11 | 2007-02-06 | 조만규 | 가정용 분전함 |
| US8540985B2 (en) | 2008-06-26 | 2013-09-24 | Orphazyme Aps | Use of Hsp70 as a regulator of enzymatic activity |
| EP2356988A4 (en) | 2008-11-18 | 2012-05-09 | Santen Pharmaceutical Co Ltd | THERAPEUTIC FOR CHORIORETINAL DEGENERATION WITH PYRIDINE-3-CARBALDEHYDE O- (PIPERIDIN-1-YL-PROPYL) OXIM DERIVATIVE AS ACTIVE SUBSTANCE |
| RU2013125923A (ru) | 2010-11-30 | 2015-01-10 | Орфазиме Апс | СПОСОБЫ УВЕЛИЧЕНИЯ ВНУТРИКЛЕТОЧНОЙ АКТИВНОСТИ Hsp70 |
| HUP1100534A2 (en) | 2011-09-26 | 2013-04-29 | Balazs Dr Hazay | Pharmaceutical composition for the treatment of muscle atrophy |
| US10709700B2 (en) | 2014-09-15 | 2020-07-14 | Orphazyme A/S | Arimoclomol formulation |
| EP3442530A1 (en) | 2016-04-13 | 2019-02-20 | Orphazyme A/S | Heat shock proteins and cholesterol homeostasis |
| KR20210059796A (ko) | 2016-04-29 | 2021-05-25 | 오르파짐 에이/에스 | 글루코세레브로시다제 연관 장애를 치료하기 위한 아리모클로몰 |
| WO2018215597A1 (en) | 2017-05-24 | 2018-11-29 | Orphazyme A/S | Heat shock protein inducers and frontotemporal disorders |
| KR20210015790A (ko) | 2018-05-28 | 2021-02-10 | 오르파짐 에이/에스 | 질환의 바이오마커로서 pbmc 샘플에서 hsp70 단백질 수준 |
| KR20230128462A (ko) | 2020-11-19 | 2023-09-05 | 제브라 덴마크 에이/에스 | 아리모클로몰 시트레이트 및 이의 중간체를 제조하기 위한 공정 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT395853B (de) * | 1991-01-31 | 1993-03-25 | Chem Pharm Forsch Gmbh | Neue imidazolderivate, verfahren zu ihrer herstellung und ihre verwendung |
| HU222994B1 (hu) * | 1995-11-02 | 2004-01-28 | BIOREX Kutató és Fejlesztő Rt. | Hidroxilaminszármazékok és azok alkalmazása sejtek molekuláris chaperon-termelésének fokozására alkalmas gyógyszerkészítmények előállítására |
| WO1997016349A1 (en) * | 1995-11-03 | 1997-05-09 | Global Trading Uk Limited | Apparatus for dispensing and filling bags at a checkout counter of a supermarket |
| UA64716C2 (en) * | 1996-08-09 | 2004-03-15 | Pharmaceuticals for therapy or prevention of illnesses connected with dysfunction of vascular endothelial cells |
-
1998
- 1998-12-14 HU HU9802897A patent/HU226617B1/hu not_active IP Right Cessation
-
1999
- 1999-07-12 UA UA2001063850A patent/UA70340C2/uk unknown
- 1999-12-07 BR BR9913982-0A patent/BR9913982A/pt not_active Application Discontinuation
- 1999-12-07 KR KR1020017002870A patent/KR100661774B1/ko not_active Expired - Fee Related
- 1999-12-07 AU AU17906/00A patent/AU765336B2/en not_active Expired
- 1999-12-07 DE DE69917074T patent/DE69917074T2/de not_active Expired - Lifetime
- 1999-12-07 AT AT99961225T patent/ATE266027T1/de active
- 1999-12-07 WO PCT/HU1999/000095 patent/WO2000035914A1/en not_active Ceased
- 1999-12-07 JP JP2000588174A patent/JP2002532498A/ja not_active Withdrawn
- 1999-12-07 RU RU2001118854/04A patent/RU2222538C2/ru not_active IP Right Cessation
- 1999-12-07 HR HR20010133A patent/HRP20010133B1/xx not_active IP Right Cessation
- 1999-12-07 US US09/762,949 patent/US6384029B1/en not_active Expired - Lifetime
- 1999-12-07 IL IL14151599A patent/IL141515A/xx not_active IP Right Cessation
- 1999-12-07 SK SK234-2001A patent/SK285582B6/sk not_active IP Right Cessation
- 1999-12-07 EP EP99961225A patent/EP1147105B1/en not_active Expired - Lifetime
- 1999-12-07 ES ES99961225T patent/ES2219091T3/es not_active Expired - Lifetime
- 1999-12-07 PT PT99961225T patent/PT1147105E/pt unknown
- 1999-12-07 SI SI9930566T patent/SI1147105T1/xx unknown
- 1999-12-07 EE EEP200100188A patent/EE04551B1/xx not_active IP Right Cessation
- 1999-12-07 DK DK99961225T patent/DK1147105T3/da active
- 1999-12-07 CZ CZ20011550A patent/CZ300764B6/cs not_active IP Right Cessation
- 1999-12-07 PL PL346767A patent/PL196584B1/pl not_active IP Right Cessation
- 1999-12-07 CA CA002340734A patent/CA2340734C/en not_active Expired - Lifetime
- 1999-12-07 RS YUP-250/01A patent/RS50129B/sr unknown
-
2001
- 2001-02-12 ZA ZA200101182A patent/ZA200101182B/en unknown
- 2001-03-14 BG BG105342A patent/BG65179B1/bg unknown
- 2001-05-10 NO NO20012310A patent/NO317649B1/no not_active IP Right Cessation
-
2011
- 2011-06-08 JP JP2011128516A patent/JP5620340B2/ja not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002532498A5 (https=) | ||
| Kantrowitz et al. | Initial clinical experience with intraaortic balloon pumping in cardiogenic shock | |
| JP5620340B2 (ja) | 光学活性ピリジル−４ｈ−１，２，４−オキサジアジン誘導体およびその血管疾患の治療における使用 | |
| JP2011201916A5 (https=) | ||
| Heller et al. | Cardiac complications: results of penetrating chest wounds involving the heart | |
| PT2091537E (pt) | Composições farmacêuticas para o tratamento da arteriopatia capilar | |
| Berger et al. | The use of diastolic augmentation with the intra-aortic balloon in human septic shock with associated coronary artery disease | |
| Naito et al. | Novel rotational speed modulation system used with venoarterial extracorporeal membrane oxygenation | |
| Bittner et al. | Myocardial performance after graft preservation and subsequent cardiac transplantation from brain-dead donors | |
| Kofidis et al. | Antegrade versus retrograde perfusion of the donor lung: impact on the early reperfusion phase | |
| TWI809313B (zh) | 血管緊張素ii受體拮抗劑代謝產物與nep抑制劑的複合物的新心衰用途 | |
| Schäfer et al. | Afterload dependent prolongation of left ventricular relaxation: importance of asynchrony | |
| Kurose et al. | Emergency and long‐term extracorporeal life support following acute myocardial infarction: Rescue from severe cardiogenic shock related to stunned myocardium | |
| Tod et al. | Thromboxane synthase inhibition and perinatal pulmonary response to arachidonic acid | |
| CN112209834B (zh) | 一种有机亚硝酸根供体及其制备方法与医药用途 | |
| Sudo et al. | Pulmonary embolectomy for acute massive pulmonary embolism under percutaneous cardiopulmonary support | |
| JP2003512419A5 (https=) | ||
| Wilson et al. | Perioperative management of calves undergoing implantation of a left ventricular assist device | |
| Payne et al. | Perioperative right heart dysfunction | |
| RU2261082C1 (ru) | Способ лечения острой дыхательной недостаточности кардиального генеза | |
| KLEINSCHMIDT et al. | The Bland‐White‐Garland syndrome. Clinical picture and anaesthesiological management | |
| RU2133612C1 (ru) | Способ восстановления сократительной функции сердца после кардиоплегии с антагонистами кальция в эксперименте | |
| Sanchez et al. | A Pale Lethargic Girl | |
| Azargoun et al. | Comparison of tissue perfusion and electrocardiogram parameters in experimentally induced hemorrhagic shock dogs resuscitated with lactated ringer and hydroxyethyl starch solutions | |
| SU1498468A1 (ru) | Способ анестезиологического пособи при операции на сердце с искусственным кровообращением |